Johnson & Johnson
Spine and other sales: $788 million (2.2 percent decrease)
More information
Stryker
Neurotechnology and spine sales: $700 million (20.7 percent increase)
More information
Medtronic Spine*
Revenue: $691 million (1.1 percent decrease)
More information
NuVasive
Revenue: $274.8 million (5.5 percent increase)
More information
Zimmer Biomet
Spine and craniomaxillofacial sales: $183 million (flat)
More information
Globus Medical
Sales: $182.9 million (5 percent increase)
More information
Orthofix
Spine sales $85.9 million (5.8 percent increase)
More information
RTI Surgical
Revenue: $69.7 million (0.2 percent decrease)
More information
SeaSpine
Revenue: $36.2 million (9 percent increase)
More information
Alpahtec Spine
Revenue: $24.6 million (15 percent increase)
More information
*indicates Q4 of fiscal year 2019
More articles on spine surgery:
42 device company executive moves in 2019
The 10 biggest device players in healthcare
Stryker ‘s stratey for Mako, K2M, sports medicine going forward
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
